基于伤残调整寿命年的2010－2019年中国登革热疾病负担评估研究

doi:10.11853/j.issn.1003.8280.2020.05.001

中国媒介生物学及控制杂志 ›› 2020, Vol. 31 ›› Issue (5): 509-512.DOI: 10.11853/j.issn.1003.8280.2020.05.001

• 全民健康助力全面小康专栏 • 下一篇

基于伤残调整寿命年的2010－2019年中国登革热疾病负担评估研究

徐朦¹, 刘小波¹, 宋秀平¹, 王艳华², 漆莉^1,3, 郭亚菲¹, 李文¹, 刘起勇¹

1 中国疾病预防控制中心传染病预防控制所媒介生物控制室, 传染病预防控制国家重点实验室, 世界卫生组织媒介生物监测与管理合作中心, 北京 102206;
2 中国疾病预防控制中心传染病预防控制所鼠疫室, 传染病预防控制国家重点实验室, 北京 102206;
3 重庆市疾病预防控制中心, 重庆 400042

收稿日期:2020-07-17 出版日期:2020-10-20 发布日期:2020-10-20
通讯作者: 刘起勇,Email:liuqiyong@icdc.cn
作者简介:徐朦,女,在读硕士,主要从事虫媒传染病研究工作,Email:xumengcdc@126.com
基金资助:
中国疾病预防控制中心传染病预防控制所公共卫生突发应急反应机制运行项目（No.131031102000180007）；国家自然科学基金青年科学基金（No.81703280）

Assessment research on the disease burden of dengue fever in China from 2010 to 2019 based on disability-adjusted life years

XU Meng¹, LIU Xiao-bo¹, SONG Xiu-ping¹, WANG Yan-hua², QI Li^1,3, GUO Ya-fei¹, LI Wen¹, LIU Qi-yong¹

1 State Key Laboratory of Infectious Disease Prevention and Control, WHO Collaborating Centre for Vector Surveillance and Management, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China;
2 National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention;
3 Chongqing Center for Disease Control and Prevention

Received:2020-07-17 Online:2020-10-20 Published:2020-10-20
Supported by:
Supported by the Emergency Response Mechanism Operation Program, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention（No.131031102000180007）and National Natural Science Foundation of China（No.81703280）

摘要/Abstract

摘要： 目的评估2010－2019年中国登革热的疾病负担，为登革热防控策略措施制定和完善卫生资源的合理配置提供依据。方法采用世界卫生组织提出的方法，结合我国法定传染病监测系统报告病例数据，应用伤残损失寿命年（YLD）、早死损失寿命年（YLL）及伤残调整寿命年（DALY）指标估算我国登革热疾病负担。结果 2010－2019年间，我国共报告91 555例登革热病例，死亡13例；病例主要集中在15~59岁，占总病例数的77.32%。归因于登革热的YLL负担累计为179人年，YLD负担累计为3 434人年，DALY负担累计为3 613人年，标化后人口的DALY为2.71人年/100万。2010－2019年DALY负担水平变化较大，由9人年增至883人年。男性与女性归因于登革热的DALY负担水平大体一致，男性DALY负担水平略高于女性，男女性比例为1.06：1。归因于登革热的疾病负担在每个年龄段均有分布，主要集中在15~、30~、45~岁3个年龄段，构成比>85%。结论 2010－2019年中国登革热疾病负担总体呈上升趋势，对人群造成的风险不断增加，建议进一步加强登革热监测和风险评估，优化卫生资源配置，为其可持续控制提供科学依据。

关键词: 登革热, 疾病负担, 伤残调整寿命年

Abstract: Objective To assess the disease burden of dengue fever in China from 2010 to 2019, and to provide a basis for formulating strategies for dengue fever prevention and control and improving the rational allocation of health resources. Methods With reference to the case data reported in China's National Notifiable Infectious Disease Surveillance System, the method proposed by the World Health Organization was used to estimate the disease burden of dengue fever in China based on the indicators of years lived with disability (YLD), years of life lost (YLL), and disability-adjusted life years (DALY). Results A total of 91 555 cases of dengue fever, including 13 deaths, were reported in China from 2010 to 2019. Most patients were aged 15-59 years, accounting for 77.32%. The cumulative YLL burden attributable to dengue fever was 179 person-years, the cumulative YLD burden was 3 434 person-years, the cumulative DALY burden was 3 613 person-years, and the normalized DALY was 2.71 person-years per million population. From 2010 to 2019, DALY burden greatly increased from 9 person-years to 883 person-years. The DALY burden due to dengue fever was similar between male and female individuals, and male individuals had a slightly higher DALY burden than female individuals, with a male/female ratio of 1.06:1. The disease burden attributable to dengue fever was distributed in all age groups, mainly 15-29 years, 30-44 years, and 45-59 years, with a constituent ratio of >85%. Conclusion The disease burden of dengue fever in China tends to increase from 2010 to 2019, causing increasing risks to the population. It is recommended to further strengthen the surveillance and risk assessment of dengue fever and optimize the allocation of health resources, so as to provide a scientific basis for sustainable control of this disease.

Key words: Dengue fever, Burden of disease, Disability adjusted life years

中图分类号:

R373.3⁺3

徐朦, 刘小波, 宋秀平, 王艳华, 漆莉, 郭亚菲, 李文, 刘起勇. 基于伤残调整寿命年的2010－2019年中国登革热疾病负担评估研究[J]. 中国媒介生物学及控制杂志, 2020, 31(5): 509-512.

XU Meng, LIU Xiao-bo, SONG Xiu-ping, WANG Yan-hua, QI Li, GUO Ya-fei, LI Wen, LIU Qi-yong. Assessment research on the disease burden of dengue fever in China from 2010 to 2019 based on disability-adjusted life years[J]. Chines Journal of Vector Biology and Control, 2020, 31(5): 509-512.

参考文献

[1] 王莹, 周良才. 登革热风险评估方法的研究及应用进展[J]. 现代预防医学, 2018, 45(15):2832-2835. Wang Y, Zhou LC. Research and application of dengue risk assessment methods[J]. Mod Prevent Med, 2018, 45(15):2832-2835.
[2] Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue[J]. Nature, 2013, 496(7446):504-507. DOI:10.1038/nature12060.
[3] 吕繁, 曾光. 疾病负担评价的理论框架及其发展[J]. 中华流行病学杂志, 2001, 22(4):259-261. DOI:10.3760/j.issn:0254-6450.2001.04.009. Lyu F, Zeng G. Theoretical framework for disease burden assessment and its development[J]. Chin J Epidemiol, 2001, 22(4):259-261. DOI:10.3760/j.issn:0254-6450.2001.04.009.
[4] 李茜瑶, 周莹, 黄辉, 等. 疾病负担研究进展[J]. 中国公共卫生, 2018, 34(5):777-780. DOI:10.11847/zgggws1118319. Li XY, Zhou Y, Huang H, et al. Progress in disease burden researches[J]. Chin J Public Health, 2018, 34(5):777-780. DOI:10.11847/zgggws1118319.
[5] GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016:a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390(10100):1260-1344. DOI:10.1016/S0140-6736(17)32130-X.
[6] Murray CJL. Quantifying the burden of disease:the technical basis for disability-adjusted life years[J]. Bull World Health Organ, 1994, 72(3):429-445.
[7] Mathers CD, Vos T, Lopez AD, et al. National burden of disease studies:a practical guide[R]. Geneva:World Health Organization, 2001:9-10.
[8] Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in southeast Asia[J]. PLoS Negl Trop Dis, 2013, 7(2):e2055. DOI:10.1371/journal.pntd.0002055.
[9] Anderson KB, Chunsuttiwat S, Nisalak A, et al. Burden of symptomatic dengue infection in children at primary school in Thailand:a prospective study[J]. Lancet, 2007, 369(9571):1452-1459. DOI:10.1016/S0140-6736(07)60671-0.
[10] 中华医学会感染病学分会, 中华医学会热带病与寄生虫学分会, 中华中医药学会急诊分会. 中国登革热临床诊断和治疗指南[J]. 中华临床感染病杂志, 2018, 11(5):321-329. DOI:10.3760/cma.j.issn.1674-2397.2018.05.001. Chinese Association of Infectious Diseases, Chinese Association of Tropical Diseases and Parasitology, Chinese Association of Traditional Chinese Medicine. Chinese guidelines for diagnosis and treatment of dengue fever[J]. Chin J Clin Infect Dis, 2018, 11(5):321-329. DOI:10.3760/cma.j.issn.1674-2397.2018.05.001.
[11] Luz PM, Grinsztejn B, Galvani AP. Disability adjusted life years lost to dengue in Brazil[J]. Trop Med Int Health, 2009, 14(2):237-246. DOI:10.1111/j.1365-3156.2008.02203.x.
[12] Undurraga EA, Betancourt-Cravioto M, Ramos-Castañeda J, et al. Economic and disease burden of dengue in Mexico[J]. PLoS Negl Trop Dis, 2015, 9(3):e0003547. DOI:10.1371/journal.pntd.0003547.
[13] Undurraga EA, Edillo FE, Erasmo JNV, et al. Disease burden of dengue in the Philippines:adjusting for underreporting by comparing active and passive dengue surveillance in Punta Princesa, Cebu city[J]. Am J Trop Med Hyg, 2017, 96(4):887-898. DOI:10.4269/ajtmh.16-0488.
[14] 孟凤霞, 王义冠, 冯磊, 等. 我国登革热疫情防控与媒介伊蚊的综合治理[J]. 中国媒介生物学及控制杂志, 2015, 26(1):4-10. DOI:10.11853/j.issn.1003.4692.2015.01.002. Meng FX, Wang YG, Feng L, et al. Review on dengue prevention and control and integrated mosquito management in China[J]. Chin J Vector Biol Control, 2015, 26(1):4-10. DOI:10.11853/j.issn.1003.4692.2015.01.002.
[15] 刘起勇. 我国登革热流行新趋势、防控挑战及策略分析[J]. 中国媒介生物学及控制杂志, 2020, 31(1):1-6. DOI:10.11853/j.issn.1003.8280.2020.01.001. Liu QY. Dengue fever in China:new epidemical trend, challenges and strategies for prevention and control[J]. Chin J Vector Biol Control, 2020, 31(1):1-6. DOI:10.11853/j.issn.1003.8280.2020.01.001.
[16] Wichmann O, Yoon IK, Vong S, et al. Dengue in Thailand and Cambodia:an assessment of the degree of underrecognized disease burden based on reported cases[J]. PLoS Negl Trop Dis, 2011, 5(3):e996. DOI:10.1371/journal.pntd.0000996.

基于伤残调整寿命年的2010－2019年中国登革热疾病负担评估研究

Assessment research on the disease burden of dengue fever in China from 2010 to 2019 based on disability-adjusted life years

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	孙钦同, 韩英男, 刘言, 王学军, 刘峰, 赖世宏, 景晓. 山东省登革热媒介白纹伊蚊生态学调查分析[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 16-20.
[2]	李天奇, 刘钦梅, 吴瑜燕, 罗明宇, 王金娜, 龚震宇. 浙江省登革热重点地区2020年白纹伊蚊幼蚊种群密度监测分析[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 21-24.
[3]	魏超, 马海芳, 廖宁, 熊绮梦. 广西壮族自治区2020－2021年登革热媒介伊蚊密度专项调查结果分析[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 25-29.
[4]	涂涛田, 肖汉森, 孟凤霞, 刘起勇, 刘小波, 何亚明, 季恒青. 重庆市2019年登革热暴发疫情应急控制后媒介伊蚊抗药性调查[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 44-47.
[5]	伦辛畅, 杨锐, 吴海霞, 王君, 刘起勇, 孟凤霞. 2005－2019年云南省缅甸登革热输入病例流行特征分析[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 108-113.
[6]	王彦丁, 李志强, 吴迪, 贡鑫然, 杨美涛, 张文义, 王勇. 基于中国知网的2011－2021年中国登革热研究进展与热点分析[J]. 中国媒介生物学及控制杂志, 2022, 33(1): 114-119.
[7]	薛海滨, 孟金霞, 任乐, 景晓. 山东省临沂市2018－2020年白纹伊蚊幼蚊监测与风险评估[J]. 中国媒介生物学及控制杂志, 2021, 32(6): 686-690.
[8]	罗兴, 刘艳春, 贾永朝. 四川省广元市2018－2020年登革热媒介伊蚊生态学特征分析[J]. 中国媒介生物学及控制杂志, 2021, 32(6): 705-709.
[9]	魏春, 郭小连, 杨锐, 唐烨榕, 岳玉娟, 刘小波, 刘起勇. 云南省2013－2020年登革热流行及聚集特征分析[J]. 中国媒介生物学及控制杂志, 2021, 32(6): 720-724.
[10]	唐娜, 董洋洋, 马建, 陈芝君, 戴罗桓, 阳益德, 贺权源, 周军华. 气象因素与登革热发病相关关系的Meta分析[J]. 中国媒介生物学及控制杂志, 2021, 32(6): 725-731.
[11]	张家林, 黄发源. 安徽省2015－2019年登革热媒介伊蚊监测结果分析[J]. 中国媒介生物学及控制杂志, 2021, 32(5): 582-585.
[12]	杨迎宇, 王莹莹, 陈芸, 付朝伟. 上海市宝山区登革热媒介伊蚊密度指数与气象因素滞后效应分析[J]. 中国媒介生物学及控制杂志, 2021, 32(3): 286-290.
[13]	伦辛畅, 赵春春, 朱彩英, 吴海霞, 王君, 王志会, 李文玉, 刘起勇, 孟凤霞. 2011－2019年柬埔寨登革热疫情及赴柬旅游对我国输入登革热的影响分析[J]. 中国媒介生物学及控制杂志, 2021, 32(3): 312-317.
[14]	徐名芳, 岳玉娟, 刘小波, 王君, 刘国军, 刘起勇, 张钦凤. 云南省瑞丽及景洪市2006－2018年登革热疫情特征比较研究[J]. 中国媒介生物学及控制杂志, 2021, 32(3): 318-323.
[15]	刘永华, 尹小雄, 张海林, 杨召兰, 董朝良, 陈思玉, 郭兆盛, 李萍. 云南省德宏州2013－2019年登革热流行特征及媒介伊蚊监测分析[J]. 中国媒介生物学及控制杂志, 2021, 32(2): 173-180.